Altogether, BHS synergizes with paclitaxel to inhibit breast cancer growth and lung metastasis by suppressing EV‐Apo/CXCL1‐induced TAM infiltration and PD‐L1 expression in an immunocompetent mouse model. Here, CXCL1 is linked to breast cancer.